Spectrum Strategic Capital Management LLC Invests $729,000 in The Ensign Group, Inc. $ENSG

Spectrum Strategic Capital Management LLC purchased a new position in The Ensign Group, Inc. (NASDAQ:ENSG) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 4,185 shares of the company’s stock, valued at approximately $729,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of ENSG. Baillie Gifford & Co. lifted its holdings in shares of The Ensign Group by 62.1% in the fourth quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after buying an additional 1,750,645 shares in the last quarter. Turtle Creek Asset Management Inc. purchased a new stake in The Ensign Group in the third quarter valued at approximately $78,840,000. Victory Capital Management Inc. raised its stake in The Ensign Group by 195.4% in the third quarter. Victory Capital Management Inc. now owns 513,328 shares of the company’s stock valued at $88,688,000 after purchasing an additional 339,534 shares in the last quarter. Wasatch Advisors LP raised its stake in The Ensign Group by 6.0% in the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its stake in The Ensign Group by 135,173.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 150,154 shares of the company’s stock valued at $26,157,000 after purchasing an additional 150,043 shares in the last quarter. 96.12% of the stock is owned by hedge funds and other institutional investors.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $177.67 on Monday. The Ensign Group, Inc. has a one year low of $134.79 and a one year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56. The firm’s 50 day simple moving average is $195.57 and its two-hundred day simple moving average is $188.91. The stock has a market capitalization of $10.38 billion, a P/E ratio of 28.94, a PEG ratio of 1.74 and a beta of 0.73.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The business had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period last year, the business earned $1.52 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, analysts expect that The Ensign Group, Inc. will post 6.79 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were issued a $0.065 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The Ensign Group’s dividend payout ratio (DPR) is currently 4.23%.

Insider Activity

In other news, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $182.21, for a total value of $127,547.00. Following the transaction, the director owned 22,052 shares in the company, valued at approximately $4,018,094.92. This trade represents a 3.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the firm’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the transaction, the director owned 9,295 shares in the company, valued at $1,858,721.15. This represents a 4.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 4,242 shares of company stock worth $862,154 over the last ninety days. Company insiders own 4.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. UBS Group set a $230.00 target price on shares of The Ensign Group and gave the company a “buy” rating in a research note on Friday, February 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a research note on Tuesday, April 21st. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Zacks Research downgraded shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the company a “hold” rating in a research note on Friday, February 6th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $216.75.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.